Peter Rahmer
See Remarks at Relay Therapeutics, Inc. (RLAY)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 28SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 4,508223,657 held (−2%) | $20.03 | $90K | -10.7% |
| Jul 30SEC | RLAYRelay Therapeutics, Inc. | Sell | 748228,165 held (−0%) | $18.61 | $14K | -3.9% |
| Jul 2SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 50,000225,857 held (−18%) | $19.09 | $954K | -6.3% |
| Apr 30SEC | RLAYRelay Therapeutics, Inc. | Sell | 753275,857 held (−0%) | $14.79 | $11K | +20.9% |
| Jan 29SEC | RLAYRelay Therapeutics, Inc. | Sell | 11,684277,964 held (−4%) | $7.62 | $89K | +134.6% |
| Jan 29SEC | RLAYRelay Therapeutics, Inc. | Sell | 1,354276,610 held (−0%) | $8.45 | $11K | +111.6% |
| Oct 30SEC | RLAYRelay Therapeutics, Inc. | Sell | 19,135358,863 held (−5%) | $7.29 | $139K | +145.3% |
| Oct 30SEC | RLAYRelay Therapeutics, Inc. | Sell | 21,394337,469 held (−6%) | $7.50 | $160K | +138.4% |
- Sell
See Remarks Peter Rahmer sold $90K of RLAY at $20.03 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Peter Rahmer sold $954K of RLAY at $19.09 — pre-scheduled 10b5-1 plan sale.